Mirum Pharmaceuticals (MIRM) Cash & Equivalents (2018 - 2026)
Mirum Pharmaceuticals' Cash & Equivalents was $330.73 million in Q2 2026, up 45.0% from $228.12 million a year earlier and up 1.8% from the prior quarter.
Powered by 
Analysis
Mirum Pharmaceuticals (MIRM) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Mirum Pharmaceuticals came in at $296.68 million, up 33.1% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 15.9% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $222.93 million in FY2024 (-22.1%), $286.33 million in FY2023 (+123.7%), $128 million in FY2022 (-2.5%) and $131.34 million in FY2021 (-7.6%).
- The Q2 2026 figure marks the highest quarterly Cash & Equivalents in data going back to Q4 2018.
- Compared with a year earlier, Cash & Equivalents has increased for four straight quarters, with growth averaging 9.6% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q3 2023 (growth of 747.5%); the worst was Q1 2022 (a decline of 49.0%).
- Per Business Quant data, MIRM's Cash & Equivalents in the three quarters before Q2 2026 was $324.91 million (Q1 2026), $296.68 million (Q4 2025) and $282.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Mirum Pharmaceuticals | 5.37 Bn | 3.79 Bn | 145.90 Mn | 330.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 330.73 Mn |
| Mar 31, 2026 | 324.91 Mn |
| Dec 31, 2025 | 296.68 Mn |
| Sep 30, 2025 | 282.02 Mn |
| Jun 30, 2025 | 228.12 Mn |
| Mar 31, 2025 | 211.82 Mn |
| Dec 31, 2024 | 222.93 Mn |
| Sep 30, 2024 | 222.97 Mn |
| Jun 30, 2024 | 233.25 Mn |
| Mar 31, 2024 | 302.84 Mn |
| Dec 31, 2023 | 286.33 Mn |
| Sep 30, 2023 | 303.06 Mn |
| Jun 30, 2023 | 297.23 Mn |
| Mar 31, 2023 | 49.42 Mn |
| Dec 31, 2022 | 128.00 Mn |
| Sep 30, 2022 | 35.76 Mn |
| Jun 30, 2022 | 55.27 Mn |
| Mar 31, 2022 | 46.27 Mn |
| Dec 31, 2021 | 131.34 Mn |
| Sep 30, 2021 | 55.84 Mn |
API Access
Mirum Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MIRM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "MIRM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MIRM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();